Acquiring Company
Passage Bio
Acquired Company
Remix Therapeutics
United StatesWatertownBiotechnologyHealthcareHealth CareGeneticsTherapeuticsBiotechnologyDescription
Passage Bio and Remix Therapeutics have announced a definitive merger agreement to combine in an all-stock transaction. Post-merger, the combined entity will operate as Remix Therapeutics. This transaction aims to advance Remix's pipeline and is supported by a $100 million private placement financing to fund operations into 2028.
Don't miss Passage Bio's next move
Get an email the moment Passage Bio makes an acquisition, hires an exec, or expands, usually minutes after it happens.
One email per event. Unsubscribe anytime.
Related People
M&A Insights
Based on deal dataFrequently asked
Who acquired Remix Therapeutics?
Remix Therapeutics was acquired by Passage Bio, based in United States. The deal was reported on June 24, 2026. Passage Bio, Inc. (NASDAQ: PASG) is a clinical-stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases. Passage Bio is publicly traded (PASG) and operates in Biotechnology.
When did Passage Bio acquire Remix Therapeutics?
Passage Bio's acquisition of Remix Therapeutics was reported on June 24, 2026. Passage Bio and Remix Therapeutics have announced a definitive merger agreement to combine in an all-stock transaction. Post-merger, the combined entity will operate as Remix Therapeutics. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Remix Therapeutics do?
Remix Therapeutics is a biotechnology company developing novel small molecule therapies designed to reprogram RNA processing and treat disease in entirely new ways. It is privately held, operating in Biotechnology, and is based in Watertown.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.